Whitehawk Therapeutics
WHWK
55 hedge funds and large institutions have $219M invested in Whitehawk Therapeutics in 2022 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 16 increasing their positions, 9 reducing their positions, and 7 closing their positions.
129% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 7
78% more repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 9
20% more funds holding
Funds holding: 46 → 55 (+9)
2.48% more ownership
Funds ownership: 58.37% → 60.85% (+2.5%)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
26% less capital invested
Capital invested by funds: $294M → $219M (-$75.1M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
+$4.3M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
+$4.05M |
| 3 |
Millennium Management
New York
|
+$3.85M |
| 4 |
EP
Eversept Partners
New York
|
+$2.89M |
| 5 |
RCMC
RK Capital Management (Colorado)
Denver,
Colorado
|
+$1.84M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
-$13M |
| 2 |
VC
Vivo Capital
Palo Alto,
California
|
-$10.2M |
| 3 |
O
OrbiMed
New York
|
-$3.08M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$1.4M |
| 5 |
HS
HighVista Strategies
Boston,
Massachusetts
|
-$979K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
TWC
51
TD Waterhouse Canada
Toronto,
Ontario, Canada
| $4K | – | – | – |
|
|
OCM
52
Ovata Capital Management
Hong Kong
| $3K | +$3.83K | +200 | New |
|
53
Osaic Holdings
Scottsdale,
Arizona
| $2K | -$3.05K | -159 | -61% |
|
|
RSCM
54
Rock Springs Capital Management
Baltimore,
Maryland
| – | -$13M | -538,835 | Closed |
|
|
O
55
OrbiMed
New York
| – | -$3.08M | -127,600 | Closed |
|
|
HS
56
HighVista Strategies
Boston,
Massachusetts
| – | -$979K | -40,549 | Closed |
|
|
SSA
57
Schonfeld Strategic Advisors
New York
| – | -$381K | -15,800 | Closed |
|
|
AWP
58
Ascent Wealth Partners
New Hartford,
New York
| – | -$241K | -10,000 | Closed |
|
|
IAG
59
Investmark Advisory Group
Shelton,
Connecticut
| – | -$2K | -100 | Closed |
|
60
Simplex Trading
Chicago,
Illinois
| – | -$1.92K | -100 | Closed |
|
WHWK Hedge Fund Activity: Q1 2022 in Review
55 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Whitehawk Therapeutics (WHWK) for Q1 2022, worth a combined $219M — down 26% from $294M a quarter earlier.
Buyers outnumbered sellers: 16 funds opened new WHWK positions and 7 closed out — a net gain of 9 holders — while 16 added to existing stakes and 9 trimmed.
The largest buyer was State Street, adding an estimated $4.3M. The largest seller was Rock Springs Capital Management, exiting entirely with an estimated $13M sold.
- 55 institutional investors held Whitehawk Therapeutics (WHWK) as of Q1 2022, up from 46 in Q4 2021.
- Funds reported $219M of Whitehawk Therapeutics stock for Q1 2022, down 26% quarter-over-quarter.
- 16 funds opened new Whitehawk Therapeutics positions in Q1 2022 and 7 closed out, a net change of +9 holders.
- The largest Whitehawk Therapeutics buyer in Q1 2022 was State Street, an estimated $4.3M added.
- The largest Whitehawk Therapeutics seller in Q1 2022 was Rock Springs Capital Management, an estimated $13M sold.
Based on aggregated 13F filings for Q1 2022.